Human microbiome engineering: The future and beyond

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 9, 2015, Pages 1-4

  Kali, Arunava ^a  

^a MAHATMA GANDHI MEDICAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Genetic engineering; Microbial flora; Microbiome engineering

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; RNA 16S; SECRETORY IMMUNOGLOBULIN;

ANTIBIOTIC THERAPY; BIOENGINEERING; DYSBIOSIS; HOST PARASITE INTERACTION; IMMUNE RESPONSE; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; RECOMBINANT DNA TECHNOLOGY; REVIEW; RNA SEQUENCE; SEQUENCE ANALYSIS; SKIN FLORA; UPREGULATION; VAGINITIS;

EID: 84941360074     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/14946.6570     Document Type: Review

References (41)

1. Scharschmidt TC, Fischbach MA. What Lives On Our Skin: Ecology, Genomics and Therapeutic Opportunities Of the Skin Microbiome. Drug Discov Today Dis Mech. 2013;10:e83-e89.
2. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 2012;489:231-41.
3. Kim BS, Jeon YS, Chun J. Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr. 2013;16:71-79.
4. Velasquez-Manoff M. Gut microbiome: the peacekeepers. Nature. 2015;518 (7540):S3-11.
5. Erdman SE, Poutahidis T. The microbiome modulates the tumor macroenvironment. OncoImmunology. 2014;3:e28271.
6. Poutahidis T, Kleinewietfeld M, Erdman SE. Gut microbiota and the paradox of cancer immunotherapy. Front Immunol. 2014;5:157.
7. Schmidt C. Mental health: Thinking from the gut. Nature. 2015;518(7540): S12-15.
8. Ruder WC, Lu T, Collins JJ. Synthetic biology moving into the clinic. Science. 2011;333:1248-52.
9. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The Human Microbiome Project. Nature. 2007;449:804-10.
10. Eisenstadt L. A new phase for the microbiome. 2013 [cited March 8, 2015]; Available from: http://www.broadinstitute.org/blog/new-phase-microbiome.
11. Gilbert JA, Meyer F, Antonopoulos D, Balaji P, Brown CT, Brown CT, et al. Meeting report: the terabase metagenomics workshop and the vision of an Earth microbiome project. Stand Genomic Sci. 2010;3:243.
12. Abbas AK, Lichtman AH. Basic Immunology: Functions and Disorders of the Immune System: Saunders/Elsevier; 2010.
13. Knight R. Why microbiome treatments could pay off soon. Nature. 2015; 518(7540):S5.
14. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci. 2010;2010: 201002611.
15. Khurana S. Human microbiome and cancer: an insight. Indian J Microbiol. 2012;52:519-20.
16. Rogers CJ, Prabhu KS, Vijay-Kumar M. The microbiome and obesity-an established risk for certain types of cancer. Cancer J. 2014;20:176-80.
17. Ley RE. The gene-microbe link. Nature. 2015;518.
18. Bucci V, Xavier JB. Towards predictive models of the human gut microbiome. J Mol Biol. 2014;426:3907-16.
19. Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol. 2012;5:403-20.
20. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013;339:548-54.
21. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics--approaching a definition. Am J Clin Nutr. 2001;73:361S-4S.
22. Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, et al. World gastroenterology organisation global guidelines: probiotics and prebiotics october 2011. J ClinGastroenterol. 2012;46:468-81.
23. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci. 2011;108:4578-85.
24. Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Regulatory T cells in cancer. Adv Cancer Res. 2010;107:57-117.
25. Miquel S, Martin R, Rossi O, Bermudez-Humaran LG, Chatel JM, Sokol H, et al. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013;16:255-61.
26. Schnorr SL. The diverse microbiome of the hunter-gatherer. Nature. 2015;518.
27. Sonnenburg JL. Microbiome engineering. Nature. 2015;518.
28. Gnanavel S. Psychobiotics: the latest psychotropics. Indian J Psychol Med. 2015;37:0253-7176.
29. Yamamoto S, Wada J, Katayama T, Jikimoto T, Nakamura M, Kinoshita S, et al. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model. Vaccine. 2010;28:6684-91.
30. Hernani Mde L, Ferreira PC, Ferreira DM, Miyaji EN, Ho PL, Oliveira ML. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice. FEMS Immunol Med Microbiol. 2011;62:263-72.
31. Daniel C, Sebbane F, Poiret S, Goudercourt D, Dewulf J, Mullet C, et al. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. Vaccine. 2009;27:1141-44.
32. Lei H, Xu Y, Chen J, Wei X, Lam DM. Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules. Virology. 2010;407:319-24.
33. Lagenaur LA, Sanders-Beer BE, Brichacek B, Pal R, Liu X, Liu Y, et al. Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol. 2011;4:648-57.
34. Duval M, Lewis CJ, Nomellini JF, Horwitz MS, Smit J, Cavacini LA. Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus. Antimicrob Agents Chemother. 2011;55:5547-52.
35. Vangelista L, Secchi M, Liu X, Bachi A, Jia L, Xu Q, et al. Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers. Antimicrob Agents Chemother. 2010;54:2994-3001.
36. Duan F, March JC. Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model. Proc Natl Acad Sci USA. 2010;107:11260-64.
37. Saeidi N, Wong CK, Lo TM, Nguyen HX, Ling H, Leong SS, et al. Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol Syst Biol. 2011;7:521.
38. Focareta A, Paton JC, Morona R, Cook J, Paton AW. A recombinant probiotic for treatment and prevention of cholera. Gastroenterology. 2006;130:1688-95.
39. Paton AW, Jennings MP, Morona R, Wang H, Focareta A, Roddam LF, et al. Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology. 2005;128:1219-28.
40. Koo OK, Amalaradjou MA, Bhunia AK. Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro. PloS One. 2012;7:e29277.
41. Sanchez B, Lopez P, Gonzalez-Rodriguez I, Suarez A, Margolles A, Urdaci MC. A flagellin-producing Lactococcus strain: interactions with mucin and enteropathogens. FEMS Microbiol Lett. 2011;318:101-07.